好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Differentiating Clinical, Imaging and Natural History Profiles of Small Volume Cerebral Infarcts by Etiology - Post-Hoc Analysis of the ENOS MR Cohort
Cerebrovascular Disease and Interventional Neurology
(-)
003
Authors/Disclosures
Deidre A. DeSilva, MD No disclosure on file
Michael Hecker, PhD (Universitatsmedizin Rostock, Klinik Fur Neurologie) No disclosure on file
No disclosure on file
Eunizar B. Omar No disclosure on file
Jennifer Manzano (UP College of Medicine/PGH) No disclosure on file
No disclosure on file
Meng C. Wong, MBBS, MMed, FAAN No disclosure on file
Hui M. Chang, MBBS (Singapore General Hospital) No disclosure on file
Jinsy Andrews, MD, FAAN (Columbia University Medical Center) Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Regeneron. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . The institution of Dr. Andrews has received research support from Calico/Platform Trial . The institution of Dr. Andrews has received research support from Corcept.
No disclosure on file